NCT02707042View on ClinicalTrials.gov

Microbial, Immune, and Metabolic Perturbations by Antibiotics (MIME Study)

PHASE1CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

March 22, 2017

Primary Completion Date

May 14, 2025

Study Completion Date

May 15, 2025

Conditions
Normal PhysiologyHealthy
Interventions
DRUG

Amoxicillin

7-day therapeutic oral course of twice daily amoxicillin

DRUG

Azithromycin

5-day oral course of once-daily azithromycin

OTHER

Control

A group of volunteers will receive no antibiotics and will serve as study controls.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT02707042 - Microbial, Immune, and Metabolic Perturbations by Antibiotics (MIME Study) | Biotech Hunter | Biotech Hunter